Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China.

[1]  T. Monaghan,et al.  Recent advances in Clostridium difficile-associated disease , 2008, Postgraduate Medical Journal.

[2]  E. Kuijper,et al.  Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  E. Kuijper,et al.  Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  Y. You,et al.  Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. , 2005, Journal of medicinal food.

[5]  S. Mineshita,et al.  The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. , 2000, The Journal of pharmacology and experimental therapeutics.

[6]  J. Brazier,et al.  PCR Targeted to the 16S-23S rRNA Gene Intergenic Spacer Region ofClostridium difficile and Construction of a Library Consisting of 116 Different PCR Ribotypes , 1999, Journal of Clinical Microbiology.